Daniel Bazarko has sold ALXN and made no open-market buys since Feb 2019
SVP, Controller, CAO at Alexion Pharmaceuticals, Inc.
SEC CIK 0001768214 · Filings on SEC.gov ↗
$0Bought
$4.0MSold
NoneLast buy
Every filing
2 filings since Feb 2019, newest first
Filings come from SEC EDGAR. Not investment advice.